Market Research Industry Reports

BioCardia Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

BioCardia Inc (BioCardia) is a clinical-stage regenerative medicine company that develops novel therapeutics for cardiovascular diseases. The company develops biotherapeutic candidate, which include CardiAMP cell therapy system, an autologous minimally processed bone marrow cells; and CardiALLO cell therapy system, an allogeneic off the shelf mesenchymal stem cell product candidate for ischemic systolic heart failure. Its CardiAMP cell therapy system comprises cell potency screening test, a point of care cell processing platform, and a biotherapeutic delivery system. BioCardia also offers catheters for use in delivery of therapeutic agents directly to the heart, and of guiding catheters for use in peripheral and coronary vasculature and chambers of the heart. The company sells its products through a network of distributors across the US. BioCardia is headquartered in San Carlos, California, the US.

BioCardia Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




BioCardia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioCardia Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioCardia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioCardia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioCardia Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioCardia Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioCardia Inc, Pharmaceuticals & Healthcare, Deal Details 11
Merger 11
Tiger X Medical Merges with BioCardia 11
Licensing Agreements 13
BioCardia Enters into Licensing and Distribution Agreement with Biomet Biologics 13
BioCardia Inc - Key Competitors 14
BioCardia Inc - Key Employees 15
BioCardia Inc - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Mar 21, 2018: BioCardia Announces Fourth Quarter 2017 Financial Results 17
Nov 10, 2017: BioCardia Reports Third Quarter 2017 Financial Results and Business Highlights 18
Corporate Communications 19
Nov 07, 2017: Dr. Ian McNiece Appointed BioCardia Chief Scientific Officer 19
Other Significant Developments 20
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables

List of Tables
BioCardia Inc, Pharmaceuticals & Healthcare, Key Facts 2
BioCardia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioCardia Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioCardia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioCardia Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BioCardia Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioCardia Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tiger X Medical Merges with BioCardia 11
BioCardia Enters into Licensing and Distribution Agreement with Biomet Biologics 13
BioCardia Inc, Key Competitors 14
BioCardia Inc, Key Employees 15

List Of Figures

List of Figures
Community Bank System, Inc., Performance Chart (2013 - 2017) 27
Community Bank System, Inc., Ratio Charts 37

BioCardia Inc - Product Pipeline Analysis, 2018 Update

BioCardia Inc (BioCardia) is a clinical-stage regenerative medicine company that develops novel therapeutics for cardiovascular diseases. The company develops biotherapeutic candidate, which include CardiAMP cell therapy system, an autologous minimally

USD 750View Report

BioCardia Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioCardia Inc (BioCardia) is a clinical-stage regenerative medicine company that develops novel therapeutics for cardiovascular diseases. The company develops biotherapeutic candidate, which include CardiAMP cell therapy system, an autologous minimally

USD 250View Report

Alexza Pharmaceuticals Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Alexza Pharmaceuticals Inc (Alexza), a wholly owned subsidiary of Ferrer Therapeutics Inc, focuses on the research, development and commercialization of novel, proprietary products for the treatment of acute central nervous

USD 250View Report

H. Lee Moffitt Cancer Center and Research Institute Inc - Medical Equipment - Deals and Alliances Profile

H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :21
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube